This is consistent with the notion that leptin is a mediator in obesity-induced HT via neurogenic mechanisms and the activation of the renin-angiotensin system, and thus may indirectly promote cardiac hypertrophy, fibrosis and ventricular remodelling [44,67]. The gene discussed is LEP; the disease is cardiac hypertrophy.